GH

Guardant Health
NASDAQ
155.35
-3.44
-2.17%
After Hours: 153.01 -2.34 -1.51% 19:51 11/10 EST
OPEN
158.71
PREV CLOSE
158.79
HIGH
160.95
LOW
153.00
VOLUME
2.43M
TURNOVER
--
52 WEEK HIGH
191.05
52 WEEK LOW
74.55
MARKET CAP
21.02B
P/E (TTM)
-42.1952
1D
5D
1M
3M
1Y
5Y
1D
Guardant360® Tissue Receives MOHW LDTS approval in Taiwan
PR Newswire · 2h ago
Learn Why The Bull Case For Guardant Health Stock Could Change Following Revenue Guidance Raise
Simply Wall St · 9h ago
Guardant Health ESMO study highlights utility of Guardant 360
TipRanks · 9h ago
PRECISION Study Published in ESMO Open Highlights Utility of Guardant360® Liquid and Guardant Reveal® to Assess Recurrence Risk After Surgery for Colorectal Cancer Metastases
Barchart · 15h ago
Guardant Health Price Target Cut to $190.00/Share From $193.00 by Piper Sandler
Dow Jones · 17h ago
Guardant Health Is Maintained at Overweight by Piper Sandler
Dow Jones · 17h ago
Piper Sandler Maintains Overweight on Guardant Health, Lowers Price Target to $190
Benzinga · 18h ago
Guardant Health Earnings Call Signals Strong Growth Momentum
TipRanks · 1d ago
More
About GH
Guardant Health, Inc. is a precision oncology company focused on guarding wellness and giving every person more time free from cancer. It provides critical insights into what drives disease through its advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the treatment for patients with advanced cancer. For patients with advanced-stage cancer, it has developed Guardant360 laboratory developed test (LDT), and Guardant360 CDx test, a comprehensive liquid biopsy test to provide tumor mutation profiling with solid tumors and to be used as a companion diagnostic in connection with non-small cell lung cancer (NSCLC), and breast cancer. It offers other tests, including Guardant360 Tissue test, Guardant Reveal blood test, Guardant360 Response blood test and others.

Webull offers Guardant Health Inc stock information, including NASDAQ: GH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GH stock methods without spending real money on the virtual paper trading platform.